Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
about
Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.How can we best respect patient autonomy in breast cancer treatment decisions?Evolution and update on current devices for prosthetic breast reconstructionImpact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancerDefining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy.Contralateral Prophylactic Mastectomy: Challenging Considerations for the SurgeonContralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.Decision making for breast cancer prevention among women at elevated riskDecision-support networks of women newly diagnosed with breast cancer.State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.Differences between Breast Conservation-Eligible Patients and Unilateral Mastectomy Patients in Choosing Contralateral Prophylactic Mastectomies.Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.Treatment experiences of Latinas after diagnosis of breast cancer.Recurrence risk perception and quality of life following treatment of breast cancer.Cancer statistics: Breast cancer in situ.Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey.Increase in contralateral prophylactic mastectomy conversation online unrelated to decision-making.Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.Women's Impression of the Expected Breast Appearance and its Association with Breast Cancer Operations.Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma.Contralateral prophylactic mastectomy: a qualitative approach to exploring the decision making process.Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study.Tradeoffs Associated With Contralateral Prophylactic Mastectomy in Women Choosing Breast Reconstruction: Results of a Prospective Multicenter Cohort.Trends in Media Reports of Celebrities' Breast Cancer Treatment Decisions.The impact of doctor-patient communication on patients' perceptions of their risk of breast cancer recurrence.Current Trends in Postmastectomy Breast Reconstruction.Is there an Ideal Breast Conservation Rate for the Treatment of Breast Cancer?Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement.
P2860
Q30489624-036431D8-6A42-42BB-97A9-59FDC62AB688Q34436508-9C98AFB2-C30B-4839-BE75-093AB9C9C488Q35066801-1F279A4C-DC52-4297-8BB3-7D447BFC3E13Q35127923-E8867366-927D-4458-9B96-C7289CC69B30Q35537770-72BDD152-EB70-4ED8-8A4F-0FF6C292A89BQ35838312-2871FC5F-CB0F-4417-9580-F68B2B0AFAAAQ36137506-A289CE87-7112-475A-AE53-6A286C978856Q36265582-6A4B1FA1-BBC1-41AC-B881-A1638D589BDDQ36300005-972E90AE-4A5B-48B3-AEE2-7D21439FEDB1Q36770162-49CDC7AE-8898-4F0F-9E5E-40DD5423BA52Q36812287-17457C72-6E78-4026-88D0-5EE5EB34F9DFQ37208201-F9B69A03-A736-4519-BA59-1E48D3796494Q37720955-384699CC-D566-40C7-9C32-C61E91319E5BQ38668021-64BE0AC6-8BD4-416E-A372-B8DA74FFC420Q38738100-3D9E469D-781C-4722-A4BB-D97E5E8149C7Q38840457-D8FEC6A5-1CEA-4442-97A7-8B62502C4C9CQ38849815-585F7A62-BEAA-4845-B246-B7FED7E57909Q38937870-DF886ACB-9842-4254-A9CC-E6A8C0059DB3Q39053012-619D62B9-B61F-49EE-8DB0-83260303A0C4Q39077474-A5BC3F5D-57B7-471A-A1C0-83388FD8F7F0Q39103033-BC931482-34A7-4557-9957-46F7AE763204Q40081153-D8EE7358-36FB-4397-BB92-6EAE07C8F8B4Q40082526-E1E9830A-6790-4132-87C2-1661621CAB9BQ40248149-6E6F3476-A0FB-49DF-AFEF-4E23114AA047Q40412658-067625AD-86E0-4FD0-A77F-5645087C141FQ40473290-CD621B17-F8BA-4EA9-B509-4E51891156E9Q41198548-2D55A09F-7630-464F-A51F-057F847BA41BQ46054763-FE1AF564-579B-4FB4-BE85-39D1151D93C5Q46217329-77828C97-87C7-4603-959C-4688490C3184Q46309220-6D827557-2EE1-45D8-9D41-7C0C12D9A7BCQ47117572-139F809B-380B-466B-9976-707592C11AD7Q47311991-EC26BD85-07E3-4BC2-833D-8BF095826E31Q47332287-FD5F392A-4054-49B7-9FDF-E3B7F950CFD9Q47415777-ECF72432-EAF5-4156-9D6F-DF3AE33FBAA5Q47779752-FC9752C3-534A-48C4-A6CA-E08F0DEDE562Q48015694-BD312886-BCB0-41C8-A2E2-AA4A4D16C161Q50076386-46322F8D-0463-476D-805D-64F5130BA20BQ53101382-1232796B-7FF6-4720-85C0-A7D5F7E5EFB7Q54710051-3765CF62-D9EB-44E1-9255-D4B0BCD055B9
P2860
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@ast
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@en
type
label
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@ast
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@en
prefLabel
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@ast
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@en
P2093
P2860
P1433
P1476
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
@en
P2093
Ann Hamilton
John J Graff
Nancy K Janz
Sarah T Hawley
Steven J Katz
P2860
P304
P356
10.1001/JAMASURG.2013.5689
P407
P577
2014-05-21T00:00:00Z